# Prophylaxis Against Surgical Site Infections Using Local as Well as Systemic Antibiotic

> **NCT07478874** · NA · COMPLETED · sponsor: **Lahore General Hospital** · enrollment: 284 (actual)

## Conditions studied

- Surgical Site Infection (SSI)

## Interventions

- **DRUG:** Cefazolin plus Gentamicin
- **DRUG:** Cefazolin

## Key facts

- **NCT ID:** NCT07478874
- **Lead sponsor:** Lahore General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07478874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07478874, "Prophylaxis Against Surgical Site Infections Using Local as Well as Systemic Antibiotic". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07478874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*